Long-term impact of co-infection by hepatitis G virus in hepatitis C virus positive renal transplant patients;Consequences a long terme d'une surinfection par le virus de l'hepatite G chez des transplantes renaux infectes par le virus de l'hepatite C

Nephrologie

Volumn 20, Issue 3, 1999, Pages 165-170

  Rostaing, L ^a   Izopet, J ^b   Arnaud, C ^b   Rumeau, J L ^b   Duffaut, M ^b   Cisterne, J M ^b   Durand, D ^b  

^a CHU RANGUEIL   (France)

^b NONE

Author keywords

Acute rejection; Chronic hepatitis; Hepatitis C virus; Hepatitis G virus; Renal transplant

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE DURATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROCONVERSION; SUPERINFECTION; FLAVIVIRUS; ISOLATION AND PURIFICATION; LIVER; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; VIROLOGY; VIRUS HEPATITIS;

ADULT; FEMALE; FLAVIVIRIDAE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0032604336     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus a transfusion-transmissible agent. Science 1996; 271: 505-8.
2. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9.
3. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334: 1536-7.
4. Theodore D, Lemon SM. GB virus C, hepatitis G virus, or human orphan flavivirus ? Hepatology 1997; 25: 1285-6.
5. Yoshiha M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-2.
6. Yoshiba M, Inoue K, Sekiyama K (letter). Hepatitis GB virus C. N Engl J Med 1996; 335: 1392-3.
7. Fukumoto T, Berg T, Naumann U, et al. (Abst). Detection of GB virus C in patients with fulminant non-A non-B hepatitis. Hepatology 1996; 63.
8. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Böker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-9.
9. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22: 1101-8.
10. Tanaka E, Alter HJ, Nakatsuji Y, Shih WK, Kimn JP, Matsumoto A, et al. Effect of hepatitis G infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740-3.
11. Bralet MP, Roudot-Thoraval F, Pawlotsky JM, Bastié A, Tran Van Nhieu A, Duval J, et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112: 188-92.
12. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-90.
13. De Lamballerie X, Charrel RN, Dussol B. Hepatitis GB virus C in patients on hemodialysis. N Engl J Med 1996; 334: 1549.
14. Izopet J, Rostaing L, Sandres K, Allal A, Pasquier C, Dubois M, et al. Impact of HGV infection in hemodialysis patients. J Am Soc Nephrol 1996; 7 (Abst): 1483.
15. Belli LS, Ideo G, Silini E. Hepatitis G virus and post-transplantation hepatitis. N Eng J Med 1996; 335: 1394-5.
16. Berg T, Naumann U, Fukumoto T, Bechstein WD, Neuhaus P, Lobeck H, et al. GB virus C infection in patients with chonic hepatitis B and C before and after liver transplantation. Transplantation 1996; 62: 711-4.
17. Udo T, Morishima T, Tsuzuki K, Orito E, Mizokami M. Hepatitis G virus in immunosuppressed paediatric allograft recipients. Lancet 1996; 348: 751.
18. Dussol B, Charrel R, de Lamballerie X, et al. Prevalence of hepatitis G virus infection in kidney transplant recipients. Transplantation 1997; 64: 537-9.
19. Szabo A, Viazov S, Heemann U, et al. GBV-C/HGV infection in renal dialysis and transplant patients. Nephrol Dial Transplant 1997; 12: 2380-4.
20. Stark K, Meyer CG, Tacke M, et al. Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients. Transplantation 1997; 64: 608-12.
21. Fabrizi F, Lunghi G, Bacchini G, et al. Hepatitis G virus infection in chronic dialysis and kidney transplant recipients. Nephrol Dial Transplant 1997; 12: 1645-51.
22. Simmonds P, Alberti A, Alter H, et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 1321-4.
23. Schlueter V, Schmolke S, Stark K, et al. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 1996; 34: 2660-4.
24. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
25. Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus. N Engl J Med 1997; 336: 741-6.
26. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-54.
27. Miyakawa Y, Mayumi M. Hepatitis G virus. A true hepatitis virus or an accidental tourist ? N Engl J Med 1997; 336: 795-6.
28. Murphy BVR, Mueroff AS, Desai SM, Lund J, Schmid CH, et al. GB hepatitis agent in cadaver organ donors and their recipients. Transplantation 1997; 63: 346-51.
29. Berenguer M, Terrault NA, Piatak M, Yu NA, Kim JP, Lau JYN, et al. Hepatitis G virus infection in patients with hepatitis C Virus infection undergoing liver transplantation. Gastroenterology 1996; 111: 1569-75.
30. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, et al. Hepatitis C viremia in chronic liver disease; relationship to interferon-α or corticosteroid treatment. Hepatology 1994; 19: 273-9.
31. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy effects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-9.
32. Roth D, Zucker K, Cirocco R, Brucke G, Giancio G, Esquenazi V, Swanson SJ, Miller J. A prospective study of hepatitis C virus infection in renal allograft recipients. Transplantation 1996; 61: 886-9.
33. Pereira BJG, Wright TL, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799-805.
34. Kliem V, van den Hoff U, Brunkhorst R, Tillmann HL, Flik J, et al. The long-term course of hepatitis C after kidney transplantation. Transplantation 1996; 62: 1417-21.
35. Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. J Am Assoc Med 1989; 261: 3607-9.
36. Reinke P, Fietze E, Ode-Hakim S, Prösch S, Lippert J, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1437-8.
37. Roth D, Zucker K, Cirocco R, DeMattos A, Burke GW, Nery J. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238.
38. Cosio FG, Sedmak DD, Henry ML, Al Haddad C, Falkenhain ME, Elkhammas EA, et al. The high prevalence of severe early post-transplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996; 62: 1054-9.